Less is more: reconsidering the need for regular use of diagnostic whole body radioiodine scintigraphy in the follow-up of differentiated thyroid cancer

Eur J Nucl Med Mol Imaging. 2017 May;44(5):741-743. doi: 10.1007/s00259-017-3632-5. Epub 2017 Feb 2.

Authors

Christian Pirich¹, Gregor Schweighofer-Zwink²

Affiliations

¹ Department of Nuclear Medicine and Endocrinology, University Hospital Salzburg Austria, Müllner Hauptstrasse 48, 5020, Salzburg, Austria. c.pirich@salk.at.
² Department of Nuclear Medicine and Endocrinology, University Hospital Salzburg Austria, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.

PMID: 28154904
DOI: 10.1007/s00259-017-3632-5

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adenocarcinoma
Follow-Up Studies
Humans
Iodine Radioisotopes*
Thyroglobulin
Thyroid Neoplasms*
Whole Body Imaging

Substances

Iodine Radioisotopes
Thyroglobulin